The Irving-based drug distribution giant said its chief strategy and business development officer plans to retire, roughly a month after welcoming a new CFO. Read on to learn more about the latest ...
CTO Bryan Harris said the firm has made progress preparing for a public offering. But timing depends on market conditions and ultimately on founder Jim Goodnight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results